Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 211 institutions that hold shares in the stock, with a total of 46.5 Million shares, which have been reported (via 13F filing form) to have a value of $6.29 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 13, 2024 Q1 2024 |
5,671,934
shares
|
$766 Million
1.32% of portfolio
|
Q1 2024
Reduced 1.34%
|
|
Westfield Capital Management CO LP
Boston, MA |
May 10, 2024 Q1 2024 |
4,075,214
shares
|
$551 Million
3.29% of portfolio
|
Q1 2024
Added 1.11%
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
3,966,666
shares
|
$536 Million
7.23% of portfolio
|
Q1 2024
Added 5.62%
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2024 Q1 2024 |
3,767,203
shares
|
$509 Million
0.32% of portfolio
|
Q1 2024
Reduced 5.7%
|
|
Wellington Management Group LLP
Boston, MA |
May 15, 2024 Q1 2024 |
2,745,872
shares
|
$371 Million
0.08% of portfolio
|
Q1 2024
New holding
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,568,903
shares
|
$347 Million
0.24% of portfolio
|
Q1 2024
Reduced 35.61%
|
|
Capital International Investors
Los Angeles, CA |
May 14, 2024 Q1 2024 |
2,191,312
shares
|
$296 Million
0.07% of portfolio
|
Q1 2024
Added 0.46%
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2024 Q1 2024 |
1,981,869
shares
|
$268 Million
0.1% of portfolio
|
Q1 2024
Added 86.13%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,781,926
shares
|
$241 Million
0.03% of portfolio
|
Q1 2024
Added 23.32%
|
|
Massachusetts Financial Services CO
Boston, MA |
May 14, 2024 Q1 2024 |
1,617,830
shares
|
$219 Million
0.08% of portfolio
|
Q1 2024
Added 6.49%
|
|
Invesco Ltd.
Atlanta, GA |
May 14, 2024 Q1 2024 |
964,663
shares
|
$130 Million
0.03% of portfolio
|
Q1 2024
Added 6.25%
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
May 15, 2024 Q1 2024 |
754,032
shares
|
$102 Million
6.64% of portfolio
|
Q1 2023
Reduced 14.39%
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
725,651
shares
|
$98 Million
0.13% of portfolio
|
Q4 2023
Reduced 6.05%
|
|
Brown Advisory Inc
|
Apr 24, 2024 Q1 2024 |
684,072
shares
|
$92.4 Million
0.14% of portfolio
|
Q1 2024
Added 35.21%
|
|
Spyglass Capital Management LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
614,107
shares
|
$83 Million
6.18% of portfolio
|
Q1 2024
Added 13.73%
|
|
Times Square Capital Management, LLC
|
May 07, 2024 Q1 2024 |
575,698
shares
|
$77.8 Million
1.27% of portfolio
|
Q1 2024
Reduced 27.4%
|
|
Vestal Point Capital, LP
New York, NY |
May 13, 2024 Q1 2024 |
525,000
shares
|
$70.9 Million
6.56% of portfolio
|
Q1 2024
Reduced 16.0%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2024 Q1 2024 |
507,952
shares
|
$68.6 Million
2.88% of portfolio
|
Q1 2024
Added 44.43%
|
|
Alliancebernstein L.P.
New York, NY |
May 14, 2024 Q1 2024 |
473,753
shares
|
$64 Million
0.03% of portfolio
|
Q1 2024
Reduced 19.56%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
457,504
shares
|
$61.8 Million
0.01% of portfolio
|
Q1 2024
Added 166.66%
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
437,092
shares
|
$59.1 Million
0.01% of portfolio
|
Q1 2024
Added 3.37%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
405,169
shares
|
$54.7 Million
0.0% of portfolio
|
Q1 2024
Added 16.09%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
362,060
shares
|
$48.9 Million
0.02% of portfolio
|
Q1 2024
Added 1516.99%
|
|
Sei Investments CO
Oaks, PA |
May 07, 2024 Q1 2024 |
346,186
shares
|
$46.8 Million
0.08% of portfolio
|
Q1 2024
Reduced 4.32%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2024 Q1 2024 |
340,118
shares
|
$45.9 Million
0.05% of portfolio
|
Q1 2024
Added 28.27%
|